Abstract:The Leucine-rich repeat kinase 2 (LRRK2) not only plays a vital role in familial forms of Parkinson's disease (PD) but is also considered as a risk factor for idiopathic PD. For these reasons, LRRK2 is considered a promising drug target for PD treatment. Its multi-domain architecture enables a fine-tuned regulation of its biological function by orchestrating intra- and inter-molecular interactions. At the same time, it offers multiple targetable epitopes for fine-tuned modulation of its deregulated kinase activity caused by pathogenic risk variants. Here, we present BioID proximity proteomes of LRRK2 revealing new interactors, which we further characterized by a novel evolutionary and structural bioinformatics pipeline. Co-evolutionary analysis of the protein-protein interaction (PPI) network identified a structural and functional module enriched in cytoskeletal components linked to the centrosome and microtubules. Likely co-evolved with LRRK2 within this cluster is CYLD, a K-63 selective ubiquitin deubiquitinase which we found to stabilize LRRK2. Furthermore, structural prediction of binary interactions via AlphaFold-multimer revealed distinct groups of interactors engaging with LRRK2 dependent on specific conformations and epitopes. We found two distinct groups engaging with LRRK2 either in an N-terminal closed ("locked") or open ("unlocked") conformation, both of which are associated with specific structurally defined interfaces and biological processes. Furthermore, we identified distinct changes in the LRRK2 proximity proteome induced by the type I kinase inhibitor MLi-2 or by co-expression of the LRRK2 upstream effector RAB29. Dependent on its state of activity and conformation, these functional state-specific protein interactions link LRRK2 to distinct cellular sub-compartments, including centriolar satellites as well as vesicular sub-compartments.

Role of the LRRK2 C-terminal tail in domain crosstalk

Two Helices Control the Dynamic Crosstalk Between the Catalytic Domains of LRRK2

Structural Model of the Dimeric Parkinson'S Protein Lrrk2 Reveals A Compact Architecture Involving Distant Interdomain Contacts

Electron Microscopy Structure of Dimeric Lrrk2 Reveals A Structural and Regulatory Role of the Cor Domain

LRRK2 binds to the Rab32 subfamily in a GTP-dependent manner via its armadillo domain

Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase dependent mechanism

Leucine-Rich Repeat Kinase 2 Binds to Neuronal Vesicles Through Protein Interactions Mediated by Its C-Terminal WD40 Domain

How Parkinson's Disease-Related Mutations Disrupt the Dimerization of WD40 Domain in LRRK2: a Comparative Molecular Dynamics Simulation Study

RedOx regulation of LRRK2 kinase activity by active site cysteines

LRRK 2 regulates mitochondrial dynamics and function through direct interaction with DLP 1

Membrane remodeling properties of the Parkinson's disease protein LRRK2

LRRK2, a puzzling protein: Insights into Parkinson's disease pathogenesis

Leucine-Rich Repeat Kinases

Proximity proteomics reveals a co-evolved LRRK2-regulatory network linked to centrosomes

Rab29-dependent asymmetrical activation of leucine-rich repeat kinase 2

Cryo-electron tomography reveals the microtubule-bound form of inactive LRRK2

Pathogenic LRRK2 regulates ciliation probability upstream of tau tubulin kinase 2 via Rab10 and RILPL1 proteins

14-3-3 binding maintains the Parkinson's associated kinase LRRK2 in an inactive state

Roles of the Drosophila Lrrk2 Homolog in Rab7-Dependent Lysosomal Positioning

A pathway for Parkinson's Disease LRRK2 kinase to block primary cilia and Sonic hedgehog signaling in the brain

Leucine-rich repeat kinase 2 regulates Sec16A at ER exit sites to allow ER-Golgi export.